Next Generation Sequencing Market By Application (Agriculture & Animal Research, Biomarker Discovery, Diagnostics, Drug Discovery, Personalized Medicine), End User (Hospitals & Clinics, Pharmaceutical & Biotechnology, Centers And Academic & Government Institutes), By Technology (Ion Semiconductor Sequencing, Pyrosequencing, Sequencing By Ligation (SBL), Sequencing By Synthesis (SBS), Single-Molecule Real-Time Sequencing (SMRT)), By Product & Services (Pre-Sequencing Products & Services, NGS Platforms, Consumables & Services For Platforms, Sequencing Services, NGS Data Analysis, Storage And Management) , Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: Jun 21, 2016

Key Findings


The global next generation sequencing market is expected to grow with aCAGR of 21.2% during the forecasted period of 2015-2022. The major factor contributing towards the growth of market isgrowing applications of next generation sequencing in the global market. The market is also driven by various factors such as rising technological innovations in sequencing platforms, rising partnerships & collaborations, increasing promotion initiatives for NGS by research laboratories & academicians etc. However, the market has been growing to its potential extent but still there are certain factors restricting the growth of global next generation sequencing market such asprecision & standardization distresses in diagnostic testing and dearth of skilled professionals.

The rising demand ofpersonalized medicine & biomarker discovery exposed, increasingemerging markets offer plentiful growth which are the key opportunities available in the global market. Rising demand for the personalized medicine is one of the most dominating factor in the market as the use of personalized medicines& survival rate has increased to 70%. With the help of personalized medicines, the breast cancers are reduced up to 34% in 2015 where 17000 strokes could be prevented by it in 2015. The use of personalized medicines is increasing because it helps to reduce the cost of healthcare. In 2015, $604 million healthcare cost was being saved by the use of personalized medicines. Various initiatives has been taken by different countries for the development of personalized medicines. In 2015, the president of a country has announced to invest $215 million for the development of personalized medicines in near future. The personalized medicines are used to cure so many diseases but the major share is hold by oncology by 38%, psychiatry 17%, Infectious diseases 10%, cardiology 7%, Endocrinology 6%, Neurology 6%, gastroenterology 5% and others accounts to 11%. The increasing use of personalized medicines has increased the scope of next generation sequencing in the global market.


Market Segment Insight


The global next generation sequencing market is segmented into end user, application, product& services, technology and geography. On the basis of end user, the market is segmented into hospitals & clinics, pharmaceutical & biotechnology companies, research centers and academic & government institutes, other. Other end user includesNPO, agrigenomics organizations, consumer genomic companies. The product& service segment is segmented into pre-sequencing products & services, NGS platforms, consumables, & services for platforms, sequencing services, NGS data analysis, storage, and management (bioinformatics). The pre-sequencing products & services is sub divided into DNA fragmentation, end repair, A-tailing, and size selection, library preparation & target enrichment and quality control. The sequencing services is further segmented into chip-Seq, de novo sequencing, exome sequencing, methyl-Seq, rna-Seq, targeted re-sequencing, whole-genome sequencing and others. The NGS data analysis, storage, and management (bioinformatics) is also sub segmented into NGS data analysis services, NGS data analysis software & workbenches and NGS storage, management, and cloud computing solutions.Technology segment is also segmented into ION semiconductor sequencing, pyrosequencing, sequencing by ligation (SBL), sequencing by synthesis (SBS), single-molecule real-time sequencing (SMRT), other. The application segment is segmented into agriculture & animal research, biomarker discovery, diagnostics, drug discovery, personalized medicine and other.


Regional Insight


Globally, the next generation sequencing market is segmented intoNorth America, Europe, APAC and ROW. North America holds the largest market share in the global next generation sequencings market followed by Europe. The dominance is driven by the increasing aging population rate which is creating a huge scope for the market. However, Asia Pacific is anticipated to grow with the eye popping CAGR during the forecasted period in the global market.The growth in the region is majorly driven by increasing and developing healthcare infrastructure in the region. The rising aging population is also creating huge opportunities in the Asia Pacific market.


Competitive Insight


Some of the keymarket players are Life Sciences Corporation (Roche Holding), Agilent Technologies, Inc., Beijing Genomics Institute, GE Healthcare, Illumina Inc., Newgene Ltd., Novartis, OXFORD GENE TECHNOLOGY, OXFORD NANOPORE TECHNOLOGIES, Pacific Biosciences of California Inc., Siemens, Acquisitions, mergers, product development, joint ventures and expansions are the key strategies adopted by the market players to sustain in the market. Roche had acquired InterMune on August, 29, 2014. InterMune is a biotechnology company which generally focus on research and development and commercialization of innovative therapies in pulmonology and fibrotic diseases. InterMune is having a brand image in UE and Canada so by acquiring InterMune the Roche is able to penetrate these markets efficiently.

CHAP 1. METHODOLOGY & SCOPE 13
1.1. RESEARCH METHODOLOGY 13
1.2. RESEARCH SCOPE & ASSUMPTIONS 13
1.3. LIST OF DATA SOURCES 13


CHAP 2. EXECUTIVE SUMMARY 14
2.1. GLOBAL NEXT GENERATION SEQUENCING MARKET SUMMARY & KEY BUYING CRITERIA 14
2.2. GLOBAL NEXT GENERATION SEQUENCING MARKET OUTLOOK 14
2.3. MARKET SEGMENTATION ANALYSIS 14
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 14
2.5. GLOBAL NEXT GENERATION SEQUENCING MARKET VALUE CHAIN ANALYSIS 14
2.6. VENDOR LANDSCAPE 14


CHAP 3. GLOBAL NEXT GENERATION SEQUENCING MARKET 15
3.1. MARKET DRIVER ANALYSIS 15
3.1.1. RISING TECHNOLOGICAL INNOVATIONS IN SEQUENCING PLATFORMS 15
3.1.2. GROWING APPLICATIONS OF NGS 15
3.1.3. RISING PARTNERSHIPS AND COLLABORATIONS 15
3.1.4. PROMOTIONAL INITIATIVES FOR NGS BY RESEARCH LABORATORIES AND ACADEMICIANS 15
3.1.5. ENTRANCE OF NEW MARKET PLAYERS 15
3.1.6. ACCUMULATIVE COGNIZANCE ON NGS PRODUCTS AND SERVICES 15
3.2. MARKET RESTRAINT ANALYSIS 15
3.2.1. PRECISION & STANDARDIZATION DISTRESSES IN DIAGNOSTIC TESTING AND DEARTH OF SKILLED PROFESSIONALS 15
3.2.2. LEGAL AND ETHICAL ISSUE ASSOCIATED WITH NEXT GENERATION SEQUENCING 15
3.3. KEY OPPORTUNITIES 15
3.3.1. RISING DEMAND OD PERSONALIZED MEDICINE & BIOMARKER DISCOVERY EXPOSED NEW AVENUES AND RISING 15
3.3.2. EMERGING MARKETS OFFER PLENTY GROWTH OPPORTUNITIES 15
3.4. CHALLENGES 15
3.4.1. UNDERSTANDING OF COMPLEX DATA FROM NGS PLATFORMS 15
3.4.2. STORAGE OF SEQUENCING DATA 15


CHAP 4. INDUSTRY ANALYSIS 16
4.1. GLOBAL NEXT GENERATION SEQUENCING MARKET– PORTER’S FIVE FORCE MODEL 16
4.2. GLOBAL NEXT GENERATION SEQUENCING MARKET– PESTEL ANALYSIS 16
4.3. GLOBAL NEXT GENERATION SEQUENCING MARKET– GAP ANALYSIS 16


CHAP 5. GLOBAL NEXT GENERATION SEQUENCING MARKET BY APLICATION 2012-2022 ($ MILLION) 17
5.1. GLOBAL AGRICULTURE & ANIMAL RESEARCH MARKET 2012-2022 ($ MILLION) 17
5.2. GLOBAL BIOMARKER DISCOVERY MARKET 2012-2022 ($ MILLION) 17
5.3. GLOBAL DIAGNOSTICS MARKET 2012-2022 ($ MILLION) 17
5.4. GLOBAL DRUG DISCOVERY MARKET 2012-2022 ($ MILLION) 17
5.5. GLOBAL PERSONALIZED MEDICINE MARKET 2012-2022 ($ MILLION) 17
5.6. GLOBAL OTHER MARKET 2012-2022 ($ MILLION) 17


CHAP 6. GLOBAL NEXT GENERATION SEQUENCING MARKET BY END USER 2012-2022 ($ MILLION) 18
6.1. GLOBAL HOSPITALS & CLINICS MARKET 2012-2022 ($ MILLION) 18
6.2. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET 2012-2022 ($ MILLION) 18
6.3. GLOBAL RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES MARKET 2012-2022 ($ MILLION) 18
6.4. GLOBAL OTHER MARKET 2012-2022 ($ MILLION) 18


CHAP 7. GLOBAL NEXT GENERATION SEQUENCING MARKET BY TECHNOLOGY 2012-2022 ($ MILLION) 19
7.1. GLOBAL ION SEMICONDUCTOR SEQUENCING MARKET 2012-2022 ($ MILLION) 19
7.2. GLOBAL PYROSEQUENCING MARKET 2012-2022 ($ MILLION) 19
7.3. GLOBAL SEQUENCING BY LIGATION (SBL) MARKET 2012-2022 ($ MILLION) 19
7.4. GLOBAL SEQUENCING BY SYNTHESIS (SBS) MARKET 2012-2022 ($ MILLION) 19
7.5. GLOBAL SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) MARKET 2012-2022 ($ MILLION) 19
7.6. GLOBAL OTHER MARKET 2012-2022 ($ MILLION) 19


CHAP 8. GLOBAL NEXT GENERATION SEQUENCING MARKET BY PRODUCT & SERVICES 2012-2022 ($ MILLION) 20
8.1. GLOBAL PRE-SEQUENCING PRODUCTS & SERVICES MARKET 2012-2022 ($ MILLION) 21
8.1.1. GLOBAL DNA FRAGMENTATION, END REPAIR, A-TAILING AND SIZE SELECTION MARKET 2012-2022 ($ MILLION) 21
8.1.2. GLOBAL LIBRARY PREPARATION & TARGET ENRICHMENT MARKET 2012-2022 ($ MILLION) 21
8.1.3. GLOBAL QUALITY CONTROL MARKET 2012-2022 ($ MILLION) 21
8.2. GLOBAL NGS PLATFORMS, CONSUMABLES, & SERVICES FOR PLATFORMS MARKET 2012-2022 ($ MILLION) 21
8.3. GLOBAL SEQUENCING SERVICES MARKET 2012-2022 ($ MILLION) 21
8.3.1. GLOBAL CHIP-SEQ MARKET 2012-2022 ($ MILLION) 21
8.3.2. GLOBAL DE NOVO SEQUENCING MARKET 2012-2022 ($ MILLION) 21
8.3.3. GLOBAL EXOME SEQUENCING MARKET 2012-2022 ($ MILLION) 21
8.3.4. GLOBAL METHYL-SEQ MARKET 2012-2022 ($ MILLION) 21
8.3.5. GLOBAL RNA-SEQ MARKET 2012-2022 ($ MILLION) 21
8.3.6. GLOBAL TARGETED RE-SEQUENCING MARKET 2012-2022 ($ MILLION) 21
8.3.7. GLOBAL WHOLE-GENOME SEQUENCING MARKET 2012-2022 ($ MILLION) 21
8.3.8. GLOBAL OTHERS MARKET 2012-2022 ($ MILLION) 21
8.4. GLOBAL NGS DATA ANALYSIS, STORAGE AND MANAGEMENT MARKET 2012-2022 ($ MILLION) 21
8.4.1. GLOBAL NGS DATA ANALYSIS SERVICES MARKET 2012-2022 ($ MILLION) 21
8.4.2. GLOBAL NGS DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET 2012-2022 ($ MILLION) 21
8.4.3. GLOBAL NGS STORAGE, MANAGEMENT AND CLOUD COMPUTING SOLUTIONS MARKET 2012-2022 ($ MILLION) 21


CHAP 9. GLOBAL NEXT GENERATION SEQUENCING MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 23
9.1. GLOBAL NEXT GENERATION SEQUENCING MARKET BY REGION 2012-2022 ($ MILLION) 23
9.2. NORTH AMERICA 23
9.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
9.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 23
9.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23
9.2.3.1. U.S. 23
9.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
9.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23
9.2.3.2. CANADA 23
9.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
9.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23
9.3. EUROPE 23
9.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
9.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 23
9.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23
9.3.3.1. GERMANY 23
9.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 24
9.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 24
9.3.3.2. UK 24
9.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 24
9.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 24
9.3.3.3. FRANCE 24
9.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 24
9.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 24
9.3.3.4. RUSSIA 24
9.3.3.4.1. RUSSIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 24
9.3.3.4.2. RUSSIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 24
9.3.3.5. REST OF EUROPE 24
9.3.3.5.1. ROE MARKET ESTIMATES AND FORECAST2012-2022($MILLION) 25
9.3.3.5.2. ROE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 25
9.4. ASIA PACIFIC 25
9.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
9.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 25
9.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
9.4.3.1. CHINA 25
9.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
9.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
9.4.3.2. INDIA 25
9.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
9.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
9.4.3.3. JAPAN 25
9.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
9.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 25
9.4.3.4. ROAPAC 25
9.4.3.4.1. ROAPAC MARKET ESTIMATES AND FORECASTS 2012-2022($MILLION) 26
9.4.3.4.2. ROAPAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($MILLION) 26
9.5. REST OF THE WORLD 26
9.5.1. REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
9.5.2. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 26
9.5.3. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
9.5.3.1. LATIN AMERICA 26
9.5.3.1.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
9.5.3.1.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
9.5.3.2. MIDDLE EAST AND AFRICA 26
9.5.3.2.1. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
9.5.3.2.2. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26


CHAP 10. COMPETITIVE LANDSCAPE 27
10.1. LIFE SCIENCES CORPORATION 28
10.1.1. COMPANY OVERVIEW 28
10.1.2. SCOT ANALYSIS 28
10.1.3. PRODUCT BENCHMARKING 28
10.1.4. STRATEGIC INITIATIVES 28
10.2. AGILENT TECHNOLOGIES, INC. 28
10.2.1. COMPANY OVERVIEW 28
10.2.2. SCOT ANALYSIS 28
10.2.3. PRODUCT BENCHMARKING 28
10.2.4. STRATEGIC INITIATIVES 28
10.3. BEIJING GENOMICS INSTITUTE 28
10.3.1. COMPANY OVERVIEW 28
10.3.2. SCOT ANALYSIS 28
10.3.3. PRODUCT BENCHMARKING 28
10.3.4. STRATEGIC INITIATIVES 28
10.4. EUROFINS SCIENTIFIC 28
10.4.1. COMPANY OVERVIEW 28
10.4.2. SCOT ANALYSIS 28
10.4.3. PRODUCT BENCHMARKING 28
10.4.4. STRATEGIC INITIATIVES 28
10.5. GATC BIOTECH AG 28
10.5.1. COMPANY OVERVIEW 28
10.5.2. SCOT ANALYSIS 28
10.5.3. PRODUCT BENCHMARKING 28
10.5.4. STRATEGIC INITIATIVES 28
10.6. GE HELATHCARE 28
10.6.1. COMPANY OVERVIEW 28
10.6.2. SCOT ANALYSIS 29
10.6.3. PRODUCT BENCHMARKING 29
10.6.4. STRATEGIC INITIATIVES 29
10.7. ILLUMINA, INC. 29
10.7.1. COMPANY OVERVIEW 29
10.7.2. SCOT ANALYSIS 29
10.7.3. PRODUCT BENCHMARKING 29
10.7.4. STRATEGIC INITIATIVES 29
10.8. MACROGEN INC. 29
10.8.1. COMPANY OVERVIEW 29
10.8.2. SCOT ANALYSIS 29
10.8.3. PRODUCT BENCHMARKING 29
10.8.4. STRATEGIC INITIATIVES 29
10.9. NEWGENE LTD. 29
10.9.1. COMPANY OVERVIEW 29
10.9.2. SCOT ANALYSIS 29
10.9.3. PRODUCT BENCHMARKING 29
10.9.4. STRATEGIC INITIATIVES 29
10.10. NOVARTIS INTERNATIONAL 29
10.10.1. COMPANY OVERVIEW 29
10.10.2. SCOT ANALYSIS 29
10.10.3. PRODUCT BENCHMARKING 29
10.10.4. STRATEGIC INITIATIVES 29
10.11. OXFORD GENE TECHNOLOGY 29
10.11.1. COMPANY OVERVIEW 29
10.11.2. SCOT ANALYSIS 29
10.11.3. PRODUCT BENCHMARKING 29
10.11.4. STRATEGIC INITIATIVES 29
10.12. OXFORD NANOPORE TECHNOLOGIES 30
10.12.1. COMPANY OVERVIEW 30
10.12.2. SCOT ANALYSIS 30
10.12.3. PRODUCT BENCHMARKING 30
10.12.4. STRATEGIC INITIATIVES 30
10.13. PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 30
10.13.1. COMPANY OVERVIEW 30
10.13.2. SCOT ANALYSIS 30
10.13.3. PRODUCT BENCHMARKING 30
10.13.4. STRATEGIC INITIATIVES 30
10.14. PERKINELMER, INC. 30
10.14.1. COMPANY OVERVIEW 30
10.14.2. SCOT ANALYSIS 30
10.14.3. PRODUCT BENCHMARKING 30
10.14.4. STRATEGIC INITIATIVES 30
10.15. QIAGEN N.V. 30
10.15.1. COMPANY OVERVIEW 30
10.15.2. SCOT ANALYSIS 30
10.15.3. PRODUCT BENCHMARKING 30
10.15.4. STRATEGIC INITIATIVES 30

TABLE 1 GLOBAL NEXT GENERATION SEQUENCING MARKET BY APLICATION 2012-2022 ($ MILLION) 30
TABLE 2 GLOBAL AGRICULTURE & ANIMAL RESEARCH MARKET 2012-2022 ($ MILLION) 30
TABLE 3 GLOBAL BIOMARKER DISCOVERY MARKET 2012-2022 ($ MILLION) 30
TABLE 4 GLOBAL DIAGNOSTICS MARKET 2012-2022 ($ MILLION) 31
TABLE 5 GLOBAL DRUG DISCOVERY MARKET 2012-2022 ($ MILLION) 31
TABLE 6 GLOBAL PERSONALIZED MEDICINE MARKET 2012-2022 ($ MILLION) 31
TABLE 7 GLOBAL OTHER MARKET 2012-2022 ($ MILLION) 31
TABLE 8 GLOBAL NEXT GENERATION SEQUENCING MARKET BY END USER 2012-2022 ($ MILLION) 31
TABLE 9 GLOBAL HOSPITALS & CLINICS MARKET 2012-2022 ($ MILLION) 31
TABLE 10 GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET 2012-2022 ($ MILLION) 31
TABLE 11 GLOBAL RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES MARKET 2012-2022 ($ MILLION) 31
TABLE 12 GLOBAL OTHER MARKET 2012-2022 ($ MILLION) 31
TABLE 13 GLOBAL NEXT GENERATION SEQUENCING MARKET BY TECHNOLOGY 2012-2022 ($ MILLION) 31
TABLE 14 GLOBAL ION SEMICONDUCTOR SEQUENCING MARKET 2012-2022 ($ MILLION) 31
TABLE 15 GLOBAL PYROSEQUENCING MARKET 2012-2022 ($ MILLION) 31
TABLE 16 GLOBAL SEQUENCING BY LIGATION (SBL) MARKET 2012-2022 ($ MILLION) 31
TABLE 17 GLOBAL SEQUENCING BY SYNTHESIS (SBS) MARKET 2012-2022 ($ MILLION) 31
TABLE 18 GLOBAL SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT) MARKET 2012-2022 ($ MILLION) 31
TABLE 19 GLOBAL OTHER MARKET 2012-2022 ($ MILLION) 31
TABLE 20 GLOBAL NEXT GENERATION SEQUENCING MARKET BY PRODUCT & SERVICES 2012-2022 ($ MILLION) 31
TABLE 21 GLOBAL PRE-SEQUENCING PRODUCTS & SERVICES MARKET 2012-2022 ($ MILLION) 31
TABLE 22 GLOBAL DNA FRAGMENTATION, END REPAIR, A-TAILING, AND SIZE SELECTION MARKET 2012-2022 ($ MILLION) 31
TABLE 23 GLOBAL LIBRARY PREPARATION & TARGET ENRICHMENT MARKET 2012-2022 ($ MILLION) 32
TABLE 24 GLOBAL QUALITY CONTROL MARKET 2012-2022 ($ MILLION) 32
TABLE 25 GLOBAL NGS PLATFORMS, CONSUMABLES & SERVICES FOR PLATFORMS MARKET 2012-2022 ($ MILLION) 32
TABLE 26 GLOBAL SEQUENCING SERVICES MARKET 2012-2022 ($ MILLION) 32
TABLE 27 GLOBAL CHIP-SEQ MARKET 2012-2022 ($ MILLION) 32
TABLE 28 GLOBAL DE NOVO SEQUENCING MARKET 2012-2022 ($ MILLION) 32
TABLE 29 GLOBAL EXOME SEQUENCING MARKET 2012-2022 ($ MILLION) 32
TABLE 30 GLOBAL METHYL-SEQ MARKET 2012-2022 ($ MILLION) 32
TABLE 31 GLOBAL RNA-SEQ MARKET 2012-2022 ($ MILLION) 32
TABLE 32 GLOBAL TARGETED RE-SEQUENCING MARKET 2012-2022 ($ MILLION) 32
TABLE 33 GLOBAL WHOLE-GENOME SEQUENCING MARKET 2012-2022 ($ MILLION) 32
TABLE 34 GLOBAL OTHERS MARKET 2012-2022 ($ MILLION) 32
TABLE 35 GLOBAL NGS DATA ANALYSIS, STORAGE AND MANAGEMENT MARKET 2012-2022 ($ MILLION) 32
TABLE 36 GLOBAL NGS DATA ANALYSIS SERVICES MARKET 2012-2022 ($ MILLION) 32
TABLE 37 GLOBAL NGS DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET 2012-2022 ($ MILLION) 32
TABLE 38 GLOBAL NGS STORAGE, MANAGEMENT AND CLOUD COMPUTING SOLUTIONS MARKET 2012-2022 ($ MILLION) 32
TABLE 39 NORTH AMERICA GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 32
TABLE 40 NORTH AMERICA GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ MILLION) 32
TABLE 41 NORTH AMERICA GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 33
TABLE 42 U.S. GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 33
TABLE 43 U.S. GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 33
TABLE 44 CANADA GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 33
TABLE 45 CANADA GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 –2022 ($ MILLION) 33
TABLE 46 CANADA GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 33
TABLE 47 EUROPE GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 33
TABLE 48 EUROPE GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ MILLION) 33
TABLE 49 EUROPE GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 33
TABLE 50 GERMANY GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 33
TABLE 51 GERMANY METABOLOMICS TECHNOLOGY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 33
TABLE 52 UK GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 33
TABLE 53 UK GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 33
TABLE 54 ASIA PACIFIC GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 33
TABLE 55 ASIA PACIFIC GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST BY REGION 2012 – 2022 ($ MILLION) 33
TABLE 56 ASIA PACIFIC GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 33
TABLE 57 CHINA GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 33
TABLE 58 CHINA GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 34
TABLE 59 INDIA GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 34
TABLE 60 INDIA GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 34
TABLE 61 JAPAN GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 34
TABLE 62 JAPAN GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 34
TABLE 63 MIDDLE EAST & AFRICA GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 34
TABLE 64 MIDDLE EAST & AFRICA GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 34
TABLE 65 LATIN AMERICA GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST 2012 – 2022 ($ MILLION) 34
TABLE 66 LATIN AMERICA GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES AND FORECAST BY APPLICATION 2012 – 2022 ($ MILLION) 34

FIGURE 1 MARKET SHARE BY REGIONS 34
FIGURE 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 4 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 5 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 6 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 7 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 8 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
FIGURE 9 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
FIGURE 10 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
FIGURE 11 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
FIGURE 12 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
FIGURE 13 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
FIGURE 14 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)